BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Hormone Replacement Therapy Market to Register 6% CAGR Driven by Growing Prevalence of Diabetes Worldwide

  Fact.MR – A Market Research and Competitive Intelligence Provider: The hormone replacement therapy market is projected to grow at a robust pace during the forecast period from 2018 to 2028, predicts Fact.MR.

  December 17, 2021

   · 

  8 min read
• Veterinary Molecular Diagnostics Market: Entry of New Vaccines and Improvements in Molecular Diagnostic Techniques to Aid Market Growth

  According to the report, the global veterinary molecular diagnostics market was valued at US$ 479.3 Mn in 2019 and is projected to expand at a CAGR of ~8% from 2020 to 2030.

  December 17, 2021

   · 

  8 min read
• Deals

  C4 Therapeutics Added to NASDAQ Biotechnology Index

  C4 Therapeutics, Inc. today announced its inclusion on the NASDAQ Biotechnology Index (Nasdaq: NBI), effective on December 20, 2021.

  December 17, 2021

   · 

  1 min read
• Business

  LifeSci Partnering & Analytics Announces Business Combination with Corsica Life Sciences and Launch of LifeSci Consulting

  LifeSci Partnering & Analytics, a division of LifeSci Partners, today announced the launch of LifeSci Consulting through a business combination with Corsica Life Sciences.

  December 17, 2021

   · 

  3 min read
• Biotech Beach

  Erasca Announces FDA Clearance of IND Application for ERAS-801 in Glioblastoma Multiforme and Collaboration with GCAR for Potential Inclusion in GBM AGILE Clinical Trial

  Erasca, Inc. today announced the United States Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for ERAS-801.

  December 17, 2021

   · 

  7 min read
• Deals

  Aquestive Therapeutics Added to NASDAQ Biotechnology Index

  Aquestive Therapeutics, Inc. today announced that NASDAQ has added the company to the NASDAQ Biotechnology Index® (Nasdaq: NBI) effective December 20, 2021.

  December 17, 2021

   · 

  10 min read
• Deals

  Entrada Therapeutics to be Added to Russell 2000® and Russell 3000® Indexes

  Entrada Therapeutics, Inc. today announced that the Company will be added to the Russell 2000 ® and Russell 3000 ® Indexes as part of the planned fourth quarter IPO additions, effective after the U.S. market opens on December 20, 2021.

  December 17, 2021

   · 

  4 min read
• Business

  Providence Therapeutics Holdings Inc., VaxThera S.A.S, and the Ministry of Health and Social Protection of the Republic of Colombia

  Providence Therapeutics announced today the signing of a Memorandum of Understanding (MOU) with VaxThera S.A.S and the Ministry of Health and Social Protection of the Republic of Colombia.

  December 17, 2021

   · 

  5 min read
• Genetown

  Omega Funds Closes Oversubscribed $650 Million Fund VII to Invest in Transformative Life Science Companies

  Omega Funds , a leading international healthcare venture capital firm focused on delivering impactful medicines to patients, today announced it has closed its seventh and largest fund with $650 million in limited partner capital commitments.

  December 17, 2021

   · 

  4 min read
• Deals

  Harmony Biosciences to be Added to the Nasdaq Biotech Index

  Harmony Biosciences Holdings, Inc. today announced that it has been selected for addition to the NASDAQ Biotechnology Index (NBI).

  December 17, 2021

   · 

  4 min read